Cargando…
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases
LESSONS LEARNED: Three‐month adjuvant capecitabine plus oxaliplatin in combination (CAPOX) appeared to reduce recurrence, with mild toxicity in postcurative resection of colorectal cancer liver metastases (CLM). Recurrence in patients who underwent the 3‐month adjuvant CAPOX after resection of CLM w...
Autores principales: | Satake, Hironaga, Hashida, Hiroki, Tanioka, Hiroaki, Miyake, Yasuhiro, Yoshioka, Shinichi, Watanabe, Takanori, Matsuura, Masato, Kyogoku, Takahisa, Inukai, Michio, Kotake, Takeshi, Okita, Yoshihiro, Matsumoto, Toshihiko, Yasui, Hisateru, Kotaka, Masahito, Kato, Takeshi, Kaihara, Satoshi, Tsuji, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265340/ https://www.ncbi.nlm.nih.gov/pubmed/33977607 http://dx.doi.org/10.1002/onco.13816 |
Ejemplares similares
-
First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study
por: Satake, Hironaga, et al.
Publicado: (2017) -
Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)
por: Satake, Hironaga, et al.
Publicado: (2017) -
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection
por: Kotake, Takeshi, et al.
Publicado: (2018) -
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)
por: Satake, Hironaga, et al.
Publicado: (2020) -
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
por: Satake, Hironaga, et al.
Publicado: (2018)